Rad AI vs TeraRecon (2026)

AI Health Index verifiedAugust 4, 2026
Verdict

Two ways to put AI into a radiology department that do not overlap as much as the category label suggests. TeraRecon is infrastructure: an advanced visualisation platform installed across roughly nineteen hundred sites and vendor independent, with a marketplace letting a health system run many partner algorithms through one route instead of integrating each separately. Rad AI never touches the image, generating the report impression from the radiologist's own dictated findings, learning their language from prior reports, and auto filling structured templates. Its oversight is the clearest in this index because the workflow enforces it: the model drafts, the radiologist signs. The governance gap to note on TeraRecon is that it does not build the algorithms it distributes and imposes no published requirement on them, so the diligence you skip on integration returns as diligence on each partner.

The case for Rad AI
  • The interoperability position is the strongest of anything in this part of the index and it is the actual product: an installed visualisation base across roughly nineteen hundred clinical sites, independent of any single scanner or archive vendor.
  • The marketplace model lets a health system run many partner algorithms through one platform rather than integrating each one, which is the practical constraint on multi algorithm deployment.
  • It holds an independent certification in its own name, and third party recognition exists rather than customer testimony alone.
The case for TeraRecon
  • It works on the report rather than the image, generating the impression from the radiologist's own dictated findings and learning that radiologist's language from their prior reports.
  • The oversight model is structurally the clearest in this index, because the workflow enforces it: the model drafts and the radiologist signs, with no path to a released report that nobody read.
  • It publishes specific falsifiable operational figures with named baselines, including follow up completion, rather than adoption counts.

This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Rad AI and TeraRecon are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded

At a Glance

Plain facts

Fact Rad AI TeraRecon
Primary category Radiology & Imaging AI Radiology & Imaging AI
Founded 2018 Not recorded
Headquarters Berkeley, California Cambridge, Massachusetts
Website radai.com terarecon.com
Attribute Matrix

Side by Side

Axis
R
Rad AI
T
TeraRecon
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Model Supply Chain Disclosure
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
AI Liability and Recourse
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage
Citable Summaries

Each record in one paragraph

Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.

Rad AI

The AI Health Index awards Rad AI its top capability grade on AI Centrality, Autonomy and Oversight Model and EHR and Interoperability Depth. Set against TeraRecon, Rad AI grades higher on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.

Source: AI Health Index, August 2026

TeraRecon

The AI Health Index awards TeraRecon its top capability grade on EHR and Interoperability Depth and Setting and Specialty Coverage. Set against Rad AI, TeraRecon grades higher on FDA and Regulatory Status and Setting and Specialty Coverage. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.

Source: AI Health Index, August 2026

FAQ

Questions buyers ask

Should we choose Rad AI or TeraRecon?

On the axes where the AI Health Index separates them, Rad AI grades higher on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency, and TeraRecon grades higher on FDA and Regulatory Status and Setting and Specialty Coverage. Rad AI leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.

Where do Rad AI and TeraRecon differ most?

The widest separation the AI Health Index records between Rad AI and TeraRecon is on AI Centrality, where Rad AI grades A and TeraRecon grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.

Where do Rad AI and TeraRecon grade the same?

The AI Health Index grades Rad AI and TeraRecon the same on several axes, including Model Supply Chain Disclosure, Clinical and Operational Evidence and Security Certifications and Trust Center. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Radiology & Imaging AI page.

Disclosure

These are complementary rather than competing and a large radiology operation may run both, since one manages algorithms against images and the other manages language in reports. TeraRecon does not build the models it distributes, so transparency questions route through to each partner algorithm and the platform imposes no published requirement on them, which is the governance gap a buyer inherits. Neither publishes pricing.

Rad AI holds no clearance for any product in its portfolio, which is consistent with reporting assistance rather than diagnosis but should be confirmed against how your organisation intends to use the carried forward findings.